BioMarin Pharmaceutical IncNASDAQ:BMRN
- LAST PRICE65.0900
- TODAY'S CHANGE (%)0.8300 (1.2916%)
- Bid / Lots63.4300/ 1
- Ask / Lots65.2500/ 1
- Open / Previous Close64.3500 / 64.2600
- Day Range
- 52 Week Range
- Volume2,172,614
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BMRN |
|---|---|---|
| 09:32 ET | 17543 | 64.345 |
| 09:33 ET | 3200 | 64.59 |
| 09:35 ET | 3913 | 64.88 |
| 09:37 ET | 4585 | 65 |
| 09:39 ET | 4834 | 65.13 |
| 09:42 ET | 6256 | 65.19 |
| 09:44 ET | 5619 | 65.06 |
| 09:46 ET | 804 | 65.01 |
| 09:48 ET | 3635 | 65.08 |
| 09:50 ET | 5397 | 65.01 |
| 09:51 ET | 3902 | 64.92 |
| 09:53 ET | 3115 | 64.871403 |
| 09:55 ET | 1570 | 64.785 |
| 09:57 ET | 2494 | 64.725 |
| 10:00 ET | 2036 | 64.63 |
| 10:02 ET | 3533 | 64.655 |
| 10:04 ET | 5228 | 64.61 |
| 10:06 ET | 1500 | 64.7232 |
| 10:08 ET | 1497 | 64.815 |
| 10:09 ET | 2498 | 64.83 |
| 10:11 ET | 3257 | 64.84 |
| 10:13 ET | 5508 | 64.87 |
| 10:15 ET | 1000 | 65.01 |
| 10:18 ET | 6385 | 65 |
| 10:20 ET | 4209 | 65.065 |
| 10:22 ET | 3313 | 65.24 |
| 10:24 ET | 3236 | 65.32 |
| 10:26 ET | 5962 | 65.33 |
| 10:27 ET | 5233 | 65.335 |
| 10:29 ET | 4874 | 65.225 |
| 10:31 ET | 3463 | 65.24 |
| 10:33 ET | 2200 | 65.22 |
| 10:36 ET | 2800 | 65.17 |
| 10:38 ET | 1235 | 65.29 |
| 10:40 ET | 2714 | 65.31 |
| 10:42 ET | 3883 | 65.35 |
| 10:44 ET | 1600 | 65.31 |
| 10:45 ET | 4300 | 65.21 |
| 10:47 ET | 500 | 65.2 |
| 10:49 ET | 3352 | 65.31 |
| 10:51 ET | 2500 | 65.275 |
| 10:54 ET | 2630 | 65.18 |
| 10:56 ET | 1702 | 65.125 |
| 10:58 ET | 5375 | 65.25 |
| 11:00 ET | 543 | 65.23 |
| 11:02 ET | 2470 | 65.37 |
| 11:03 ET | 3200 | 65.21 |
| 11:05 ET | 1626 | 65.315 |
| 11:07 ET | 2200 | 65.25 |
| 11:09 ET | 5200 | 65.2992 |
| 11:12 ET | 3441 | 65.245 |
| 11:14 ET | 3783 | 65.26 |
| 11:16 ET | 500 | 65.205 |
| 11:18 ET | 2300 | 65.205 |
| 11:20 ET | 2305 | 65.23 |
| 11:21 ET | 3514 | 65.14 |
| 11:23 ET | 6683 | 65.125 |
| 11:25 ET | 1425 | 65.24 |
| 11:27 ET | 4299 | 65.21 |
| 11:30 ET | 1200 | 65.235 |
| 11:32 ET | 2662 | 65.18 |
| 11:34 ET | 7403 | 65.12 |
| 11:36 ET | 2800 | 65.06 |
| 11:38 ET | 11607 | 65.07 |
| 11:39 ET | 5341 | 65.08 |
| 11:41 ET | 2340 | 65.14 |
| 11:43 ET | 2770 | 65.065 |
| 11:45 ET | 20494 | 65.13 |
| 11:48 ET | 5102 | 65.105 |
| 11:50 ET | 4915 | 65.04 |
| 11:52 ET | 2376 | 65.02 |
| 11:54 ET | 10439 | 65.16 |
| 11:56 ET | 2640 | 65.27 |
| 11:57 ET | 2900 | 65.23 |
| 11:59 ET | 500 | 65.2 |
| 12:01 ET | 3141 | 65.22 |
| 12:03 ET | 1740 | 65.18 |
| 12:06 ET | 4347 | 65.26 |
| 12:08 ET | 300 | 65.21 |
| 12:10 ET | 2560 | 65.23 |
| 12:12 ET | 3280 | 65.345 |
| 12:14 ET | 5594 | 65.31 |
| 12:15 ET | 2240 | 65.21 |
| 12:17 ET | 1603 | 65.205 |
| 12:19 ET | 3177 | 65.21 |
| 12:21 ET | 13833 | 65.15 |
| 12:24 ET | 12598 | 65.245 |
| 12:26 ET | 7920 | 65.325 |
| 12:28 ET | 100 | 65.29 |
| 12:30 ET | 8186 | 65.27 |
| 12:32 ET | 13658 | 65.28 |
| 12:33 ET | 4238 | 65.245 |
| 12:35 ET | 1215 | 65.29 |
| 12:37 ET | 2056 | 65.265 |
| 12:39 ET | 3021 | 65.38 |
| 12:42 ET | 6237 | 65.475 |
| 12:44 ET | 11094 | 65.45 |
| 12:46 ET | 5804 | 65.41 |
| 12:48 ET | 2737 | 65.37 |
| 12:50 ET | 9174 | 65.46 |
| 12:51 ET | 7995 | 65.4206 |
| 12:53 ET | 2316 | 65.44 |
| 12:55 ET | 8474 | 65.57 |
| 12:57 ET | 11431 | 65.5801 |
| 01:00 ET | 9896 | 65.665 |
| 01:02 ET | 2950 | 65.61 |
| 01:04 ET | 3483 | 65.52 |
| 01:06 ET | 1482 | 65.52 |
| 01:08 ET | 4824 | 65.565 |
| 01:09 ET | 132 | 65.5202 |
| 01:11 ET | 14878 | 65.6 |
| 01:13 ET | 2442 | 65.42 |
| 01:15 ET | 3498 | 65.36 |
| 01:18 ET | 600 | 65.335 |
| 01:20 ET | 3867 | 65.35 |
| 01:22 ET | 40336 | 65.28 |
| 01:24 ET | 1114 | 65.28 |
| 01:26 ET | 1000 | 65.3 |
| 01:27 ET | 4602 | 65.345 |
| 01:29 ET | 3874 | 65.29 |
| 01:31 ET | 8838 | 65.27 |
| 01:33 ET | 4199 | 65.2871 |
| 01:36 ET | 1919 | 65.305 |
| 01:38 ET | 2355 | 65.23 |
| 01:40 ET | 1887 | 65.13 |
| 01:42 ET | 2619 | 65.17 |
| 01:44 ET | 11615 | 65.31 |
| 01:45 ET | 3827 | 65.32 |
| 01:47 ET | 2079 | 65.31 |
| 01:49 ET | 1663 | 65.22 |
| 01:51 ET | 4540 | 65.23 |
| 01:54 ET | 900 | 65.205 |
| 01:56 ET | 2232 | 65.17 |
| 01:58 ET | 5038 | 65.255 |
| 02:00 ET | 500 | 65.25 |
| 02:02 ET | 2968 | 65.23 |
| 02:03 ET | 4166 | 65.225 |
| 02:05 ET | 426 | 65.2 |
| 02:07 ET | 10504 | 65.225 |
| 02:09 ET | 1482 | 65.225 |
| 02:12 ET | 1100 | 65.225 |
| 02:14 ET | 2067 | 65.26 |
| 02:16 ET | 5856 | 65.2 |
| 02:18 ET | 2672 | 65.215 |
| 02:20 ET | 3400 | 65.22 |
| 02:21 ET | 7123 | 65.29 |
| 02:23 ET | 6407 | 65.2083 |
| 02:25 ET | 2697 | 65.25 |
| 02:27 ET | 10171 | 65.17 |
| 02:30 ET | 11470 | 65.2 |
| 02:32 ET | 4131 | 65.15 |
| 02:34 ET | 5519 | 65.13 |
| 02:36 ET | 3078 | 65.16 |
| 02:38 ET | 1100 | 65.16 |
| 02:39 ET | 4306 | 65.09 |
| 02:41 ET | 3171 | 65.18 |
| 02:43 ET | 3830 | 65.21 |
| 02:45 ET | 874 | 65.21 |
| 02:48 ET | 3859 | 65.23 |
| 02:50 ET | 4017 | 65.195 |
| 02:52 ET | 2726 | 65.22 |
| 02:54 ET | 3224 | 65.25 |
| 02:56 ET | 3348 | 65.22 |
| 02:57 ET | 3019 | 65.22 |
| 02:59 ET | 9681 | 65.25 |
| 03:01 ET | 3718 | 65.265 |
| 03:03 ET | 3026 | 65.265 |
| 03:06 ET | 2875 | 65.27 |
| 03:08 ET | 5897 | 65.31 |
| 03:10 ET | 3665 | 65.29 |
| 03:12 ET | 6207 | 65.4 |
| 03:14 ET | 5685 | 65.47 |
| 03:15 ET | 9553 | 65.4 |
| 03:17 ET | 10284 | 65.41 |
| 03:19 ET | 7262 | 65.51 |
| 03:21 ET | 5782 | 65.46 |
| 03:24 ET | 3367 | 65.445 |
| 03:26 ET | 2800 | 65.46 |
| 03:28 ET | 7336 | 65.5 |
| 03:30 ET | 5025 | 65.49 |
| 03:32 ET | 6786 | 65.56 |
| 03:33 ET | 3554 | 65.54 |
| 03:35 ET | 10133 | 65.545 |
| 03:37 ET | 9364 | 65.58 |
| 03:39 ET | 1400 | 65.56 |
| 03:42 ET | 11264 | 65.505 |
| 03:44 ET | 6400 | 65.5899 |
| 03:46 ET | 9567 | 65.49 |
| 03:48 ET | 4635 | 65.41 |
| 03:50 ET | 6961 | 65.355 |
| 03:51 ET | 9136 | 65.33 |
| 03:53 ET | 15053 | 65.16 |
| 03:55 ET | 18832 | 65.15 |
| 03:57 ET | 43664 | 65.09 |
| 04:00 ET | 605570 | 65.09 |
Nov 16, 2024
BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO(R) (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024, from 10:45AM ET on Saturday Nov 16, 2024 by Dow Jones
10:45AM ET on Saturday Nov 16, 2024 by Dow Jones
Nov 15, 2024
DJ BioMarin Pharmaceutical Initiated at Outperform by Wolfe Research, from 5:26AM ET on Friday Nov 15, 2024 by Dow Jones
5:26AM ET on Friday Nov 15, 2024 by Dow Jones
Nov 6, 2024
BioMarin to Participate in Three Upcoming Investor Conferences, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
Oct 30, 2024
DJ BioMarin Pharmaceutical Is Maintained at Neutral by Citigroup, from 2:44PM ET on Wednesday Oct 30, 2024 by Dow Jones
2:44PM ET on Wednesday Oct 30, 2024 by Dow JonesDJ BioMarin Pharmaceutical Is Maintained at Hold by Canaccord Genuity, from 1:36PM ET on Wednesday Oct 30, 2024 by Dow Jones
1:36PM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BioMarin Pharmaceutical Inc | 12.2B | 39.1x | --- |
Exact Sciences Corp | 9.8B | -47.1x | --- |
Neurocrine Biosciences Inc | 12.7B | 34.0x | +62.04% |
Medpace Holdings Inc | 10.5B | 29.6x | +35.10% |
United Therapeutics Corp | 16.6B | 16.2x | +8.22% |
Qiagen NV | 9.5B | 106.0x | +12.66% |
Company Information
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease.
Contact Information
- Headquarters
- 105 Digital DriveNOVATO, CA, United States 94949
- Phone
- 415-505-6700
- Fax
- 415-382-7889
Executives
- Non-Executive Independent Chairman of the Board
- Richard Meier
- President, Chief Executive Officer, Director
- Alexander Hardy
- Chief Financial Officer, Executive Vice President - Finance
- Brian Mueller
- President - Worldwide Research and Development
- Henry Fuchs
- Executive Vice President - Global Manufacturing and Technical Operations, Chief Technical Officer
- C. Greg Guyer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.2B |
|---|---|
Revenue (TTM) | $2.8B |
Shares Outstanding | 190.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.29 |
EPS | $1.66 |
Book Value | $26.25 |
P/E Ratio | 39.1x |
Price/Sales (TTM) | 4.4 |
Price/Cash Flow (TTM) | 29.0x |
Operating Margin | 11.81% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
